|
| Figure 4: Schematic diagram of proposed “NBDM” to eliminate of HIV and gp120 from the patients’ blood treated by T-nanaomagnets. Main features include: (a) Syringe containing T-nanomagnets (b) patient (c) arterial blood (d) arterial pressure monitor (e ) blood pump (f) heparin pump (g) dialyzer inflow pressure monitor (h) dialyzer (i) electromagnetic field (j) magnetic nanoparticles (k) venous pressure monitor, (l) air trap and air detector, and (m) T-nanomagnet and gp120 cleaned-blood injects to patient. |
